Cincinnati, OH, United States of America

Aerpio Pharmaceuticals, Inc.


USPTO Granted Patents = 8



Forward Citations = 52

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Kevin Gene Peters (7 out of 34 patents)

silverMedal Michael Allen Flynn (3 out of 6 patents)

bronzeMedal James Copp (1 out of 1 patent)

4 Jeffrey Lyle Gray (1 out of 23 patents)

5 Cynthia Monesa Clark (1 out of 16 patents)

6 Ryan Matthew Nichols (1 out of 16 patents)

7 Matthew B Maier (1 out of 16 patents)

8 Kande K D Amarasinghe (1 out of 16 patents)

9 Robert A Shalwitz (1 out of 33 patents)

10 John M Janusz (1 out of 36 patents)


8 patents:

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for ocular diseases, specifically targeting the bioactive lipid mediator sphingosine-1-phosphate (S1P) pathway. Their lead product candidate, razuprotafib, is currently in clinical development for diabetic retinopathy, where abnormal S1P signaling plays a key role in the underlying pathology. Aerpio is dedicated to advancing innovative therapies to improve outcomes for patients with sight-threatening conditions.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#129 in Cincinnati, OH

#1,386 in Ohio

#34,852 in US

...
Cincinnati, OH, United States of America
Forward Citations = 52

10 inventors:

Please report any incorrect information to support@idiyas.com
Loading…